Reducing Radiation Exposure to the
Citizens of North Carolina
North Carolina Department of Environment and Natural Resources

N. C. Regulations for Protection Against Radiation

To navigate, select a Section from the list.  Sections with an asterisk (*) indicate recently amended regulations are contained in that Section

 

 

15A NCAC 11 .0361          MEDICAL USE OF UNSEALED RADIOACTIVE MATERIAL

(a)  A licensee may use any unsealed radioactive material prepared for use for uptake, dilution, or excretion studies, imaging and localization studies and radiopharmaceutical therapy that is:

(1)           Obtained from a manufacturer or preparer licensed under 10 CFR 32.72 or equivalent Agreement State requirements;

(2)           Prepared by:

(A)          An authorized nuclear pharmacist;

(B)           A physician who is an authorized user identified on a North Carolina Radioactive Materials License, an Agreement State Radioactive Materials License, or a license issued by the U.S. Nuclear Regulatory Commission or who meets the requirements in 15A NCAC 11 .0117(a)(2);

(C)           An individual under the supervision, as specified in Rule .0318 of this Section, of the authorized nuclear pharmacist in Part (a)(2)(A) of this Rule or the physician who is an authorized user in Part (a)(2)(B) of this Rule;

(3)           Obtained from and prepared by an NRC or Agreement State licensee for use in research in accordance with a Radioactive Drug Research Committee-approved protocol or an Investigational New Drug (IND) protocol accepted by the FDA; or

(4)           Prepared by the licensee for use in research in accordance with a Radioactive Drug Research Committee-approved protocol or an Investigational New Drug (IND) protocol accepted by the FDA.

(b)  A licensee shall not administer to humans a radiopharmaceutical containing more than 0.15 microcurie (0.15 kilobecquerel) of molybdenum-99 per millicurie (megabecquerel) of technetium-99m.

(c)  A licensee that uses molybdenum-99/technetium-99m generators for preparing a technetium-99m radiopharmaceutical shall measure the molybdenum-99 concentration in the first eluate after receipt of a generator to demonstrate compliance with Paragraph (b) of this Rule.

(d)  A licensee that must measure molybdenum concentration shall retain a record of each measurement for three years.  The record shall include for each measured elution of technetium-99m:

(1)           the ratio of the measures expressed as microcuries of molybdenum-99 per millicurie of technetium-99m (or kilobecquerels of molybdenum-99 per megabecquerel of technetium-99m);

(2)           the time and date of the measurement; and

(3)           the initials of the individual who made the measurement.

 

History Note:        Authority G.S. 104E-7(a)(2); 104E-10(b); 104E-12;

Eff. April 1, 1999;

Amended Eff. November 1, 2007.

 

Top.gif (1234 bytes) Top of Page Go Back One Page Back one page Go Forward One Page Forward one page RPS Home Page

Page Last Modified:  14 April 2008
 Line separating content from footer

NC DENR Home Page       

NC Radiation Protection, 1645 Mail Service Center,
Raleigh, NC  27699-1645  919-571-4141  Fax  919-571-4148

One NC Naturally